The ATM program expansion signals ongoing cash burn and reliance on equity financing. With the stock trading at $3.24 (36% below the $5.11 reference price), any ATM sales will be highly dilutive. Monitor for volume spikes indicating active selling into the market. No revenue or earnings data in this filing to assess fundamental trajectory.
Price Chart
Executive Summary
NeuroOne Medical Technologies filed a prospectus supplement to increase its ATM offering capacity from $8.4M already sold to a new total of $13.4M, and concurrently filed an 8-K reporting this update. The company has already raised $8.36M through the ATM program since December 2022. At a $28M market cap, the potential for up to $5M in additional dilution represents roughly 18% of current market value, a material overhang for a micro-cap stock.
Key Facts
- Company increased ATM offering capacity to $13,400,000 total
- Already sold approximately $8,359,586 under the ATM program
- Stock closed at $3.24 on June 11, 2026, down from $5.11 reference price used for public float calculation
- Market cap is approximately $28M, making the remaining $5M potential dilution ~18% of market value
- Non-affiliate public float was approximately $41.48M based on 8.1M shares at $5.11
Financial Impact
Up to $5M in additional share issuance potential, representing ~18% of current $28M market cap
Risk Factors
- Continued dilution from ATM sales at depressed stock price
- No disclosure of cash runway or revenue to evaluate funding needs
- Micro-cap with limited liquidity — ATM sales could pressure stock further
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (NMTC) — Batch item 1 | 0001213900-26-068329 |
| Document: 0001213900-26-068329-index-headers.html | 0001213900-26-068327 |
| Document: 0001213900-26-068329-index.html | 0001213900-26-068329 |
| Document: 0001213900-26-068329.txt | 0001213900-26-068329 |
| 8-K Filing (NMTC) — Batch item 5 | 0001213900-26-068327 |
| Document: ea029446601ex5-1.htm | 0001213900-26-068329 |
| Document: 0001213900-26-068327-index-headers.html | 0001213900-26-068329 |
| Document: 0001213900-26-068327-index.html | 0001213900-26-068329 |
| Document: 0001213900-26-068327.txt | 0001213900-26-068329 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 8-K | $1.12 $1.13 | ▲ +1.35% | ▲ +0.80% | $0.8039 (−27.90%) |
Oct 5, 2026 21d ago | Press Release | $1.12 $1.13 | ▲ +1.35% | ▲ +0.80% | $0.8039 (−27.90%) |
Aug 27, 2026 8w ago | 8-K | $1.98 $1.77 | ▼ −10.61% | ▼ −10.38% | $0.8039 (−59.40%) |
Aug 13, 2026 10w ago | 8-K | $1.83 $1.94 | ▲ +6.01% | ▲ +6.21% | $0.8039 (−56.07%) |
Jun 12, 2026 19w ago | 424B5 / 8-K | $3.32 $3.25 | ▲ +2.11% | ▲ +1.51% | $0.8039 (+75.79%) |
May 22, 2026 22w ago | 8-K | $3.87 $3.73 | ▲ +3.62% | ▲ +3.63% | $0.8039 (+79.23%) |
May 12, 2026 23w ago | 8-K | $4.39 $4.51 | ▲ +2.73% | ▲ +2.16% | $0.8039 (−81.69%) |
May 4, 2026 25w ago | 8-K | $4.49 $4.43 | ▼ −1.34% | ▼ −2.13% | $0.8039 (−82.10%) |
Apr 30, 2026 25w ago | 8-K | $4.70 $4.35 | ▼ −7.45% | ▼ −7.67% | $0.8039 (−82.90%) |
Feb 25, 2026 34w ago | 8-K | $4.15 $4.02 | ▼ −3.04% | ▼ −2.59% | $0.8039 (−80.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers